ALAN LIST, MD
Osteopathic Medicine at Usf Magnolia Dr, Tampa, FL
License number
Florida ME93632
Category
Osteopathic Medicine
Type
Hematology
Address
Address
2
12902 Usf Magnolia Dr, Tampa, FL 33612
PO Box 917770, Orlando, FL 32891
PO Box 917770, Orlando, FL 32891
Phone
(813) 745-3980
Personal information
See more information about ALAN LIST at radaris.comName
Address
Phone
15706 Cochester Rd, Tampa, FL 33647
15706 Cochester Rd, Tampa, FL 33647
Organization information
See more information about ALAN LIST at bizstanding.comAlan List MD
12902 Usf Magnolia Dr, Tampa, FL 33612
Industry:
Internist
Phone:
(888) 860-2778 (Phone)
Alan Francis List
Professional information
See more information about ALAN LIST at trustoria.com
Dr. Alan List, Tampa FL - MD (Doctor of Medicine)
Dr. Alan List, Tampa FL - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
12902 Usf Magnolia Dr, Tampa 33612
(813) 972-4673 (Phone)
(813) 972-4673 (Phone)
Certifications:
Hematology, 1986, Internal Medicine, 1983, Medical Oncology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
12902 Usf Magnolia Dr, Tampa 33612
H. Lee Moffitt Cancer Center and Research Institute I.
12902 Usf Magnolia Dr, Tampa 33612
H. Lee Moffitt Cancer Center and Research Institute I.
12902 Usf Magnolia Dr, Tampa 33612
Education:
Medical School
University Of Pennsylvania School Of Medicine
Graduated: 1980
Good Samaritan Regional Med Center
Graduated: 1983
Vanderbilt University Med Center
Graduated: 1985
Graduated: 1986
University Of Pennsylvania School Of Medicine
Graduated: 1980
Good Samaritan Regional Med Center
Graduated: 1983
Vanderbilt University Med Center
Graduated: 1985
Graduated: 1986
Alan F List, Tampa FL
Alan F List, Tampa FL
Specialties:
Hematologist
Address:
12902 Usf Magnolia Dr, Tampa, FL 33612
Education:
University of Pennsylvania, Perelman School of Medicine - Doctor of Medicine
Vanderbilt University Medical Center - Fellowship - Hematology
Vanderbilt University Medical Center - Residency - Oncology (Internal Medicine)
Banner Good Samaritan Medical Center - Residency - Internal Medicine
Vanderbilt University Medical Center - Fellowship - Hematology
Vanderbilt University Medical Center - Residency - Oncology (Internal Medicine)
Banner Good Samaritan Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Alan F List, Tampa FL
Alan F List, Tampa FL
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology, Hematology
Work:
H. Lee Moffitt Cancer Center & Research Ins
12902 Usf Magnolia Dr, Tampa, FL 33612
12902 Usf Magnolia Dr, Tampa, FL 33612
Education:
University of Pennsylvania(1980) Medical Oncology
Executive Vp, &Amp; Physician In Chief At Moffitt Cancer Center
Executive Vp, &Amp; Physician In Chief At Moffitt Cancer Center
Position:
Executive VP, & Physician in Chief at Moffitt Cancer Center
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Hospital & Health Care
Work:
Moffitt Cancer Center
-
Executive VP, & Physician in Chief
Physician-In-Chief At Moffitt Cancer Center
Physician-In-Chief At Moffitt Cancer Center
Position:
Physician-in-Chief at Moffitt Cancer Center
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Hospital & Health Care
Work:
Moffitt Cancer Center
-
Physician-in-Chief
Method Of Identifying Myelodysplastic Syndromes
Method Of Identifying Myelodysplastic Syndromes
US Patent:
2012031, Dec 13, 2012
Filed:
Jul 30, 2012
Appl. No.:
13/561687
Inventors:
Alan F. List - Tampa FL, US
Lubomir Sokol - Tampa FL, US
Lubomir Sokol - Tampa FL, US
Assignee:
H. Lee Moffitt Cancer Center and Research Institute, Inc. - Tampa FL
International Classification:
C40B 30/04, C12Q 1/68
US Classification:
506 9, 435 612, 435 611
Abstract:
Myelodysplastic syndromes display both hematological and biological heterogeneity with variable leukemia potential. To determine whether microRNAs expression offers diagnostic discrimination or influences malignant potential in MDS, bone marrow miRNA expression was investigated from prognostically distinct MDS subsets using a microarray platform. After background subtraction and normalization, data were analyzed indicating thirteen miRNA signature with statistically significant differential expression, including down-regulation of members of a leukemia associated miRNA family. A unique signature consisting of 10 miRNAs was closely associated with International Prognostic Scoring System risk category permitting discrimination between lower and higher risk disease. Selective overexpression of miRNA-181 family members was detected in higher risk MDS, indicating pathogenetic overlap with acute myeloid leukemia. Analysis of miRNA expression profile offers diagnostic utility, and provides pathogenetic and prognostic discimination in MDS.